» Articles » PMID: 35136759

Comprehensive Study on Clinical Responses and Socioeconomic Characteristics of COVID-19 Patients During Outbreak

Overview
Specialty Public Health
Date 2022 Feb 9
PMID 35136759
Authors
Affiliations
Soon will be listed here.
Abstract

The severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2) causes coronavirus disease 2019 (COVID-19) and emerged as a new public health crisis. This RNA virus, which has an origin in bats, is phenotypically and genotypically diverse. The source of transmission is by direct inhalation or contact with infected droplets or indirect through fomites. The disease shows an average incubation period of 2 to 14 days. The general symptoms include fever, cough, sore throat, breathlessness, fatigue, and malaise, although in a few it is found to be asymptomatic. The immune response shows variation from individual to individual, which varies from pneumonia, chest pain, acute respiratory distress syndrome, and multiorgan failure leading to death. The cytokine and chemokine responses play a major role in the severity of the infection. Laboratory diagnosis is done by molecular investigations. The socioeconomic conditions of individuals also play a role in disease manifestation. Treatment is supportive with symptomatic management. Preventive measures include social distancing, use of face masks, and contact tracing. This review will present a general overview of coronavirus and describe the clinical and socioeconomic features of the COVID-19 patients. It will also introduce comprehensive data of symptomatic and asymptomatic patients among different Asian and Western countries during the current pandemic. Furthermore, it also focuses on the most up-to-date information on effective management and prevention of COVID-19.

Citing Articles

Prominent Anti-UVC Activity of Lignin Degradation Products.

Sakagami H, Amano S, Uota S, Tanuma S, Inomata M, Shindo A In Vivo. 2022; 36(6):2689-2699.

PMID: 36309360 PMC: 9677805. DOI: 10.21873/invivo.13004.


Comparison of UVC Sensitivity and Dectin-2 Expression Between Malignant and Non-malignant Cells.

Shindo A, Kusano M, Sakagami H, Amano S, Inomata M, Abe M In Vivo. 2022; 36(5):2116-2125.

PMID: 36099100 PMC: 9463890. DOI: 10.21873/invivo.12937.

References
1.
Jia J, Hu X, Yang F, Song X, Dong L, Zhang J . Epidemiological Characteristics on the Clustering Nature of COVID-19 in Qingdao City, 2020: A Descriptive Analysis. Disaster Med Public Health Prep. 2020; 14(5):643-647. PMC: 7156571. DOI: 10.1017/dmp.2020.59. View

2.
Joshi J, Mishra P, Kamar S, Sharma N, Parajuli J, Sharma S . Clinical Profile of Cases of COVID-19 in Far Western Province of Nepal. J Nepal Health Res Counc. 2020; 18(1):135-137. DOI: 10.33314/jnhrc.v18i1.2602. View

3.
Wang Z, Chen X, Lu Y, Chen F, Zhang W . Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 2020; 14(1):64-68. DOI: 10.5582/bst.2020.01030. View

4.
Tambe M, Parande M, Tapare V, Borle P, Lakde R, Shelke S . An epidemiological study of laboratory confirmed COVID-19 cases admitted in a tertiary care hospital of Pune, Maharashtra. Indian J Public Health. 2020; 64(Supplement):S183-S187. DOI: 10.4103/ijph.IJPH_522_20. View

5.
Totura A, Baric R . SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr Opin Virol. 2012; 2(3):264-75. PMC: 7102726. DOI: 10.1016/j.coviro.2012.04.004. View